Monoclonal gammopathy is a condition where plasma cells produce an abnormal protein called M protein, which can lead to multiple myeloma. It is often diagnosed through blood tests and does not require treatment, but regular checkups are recommended to monitor for cancer.
Monoclonal gammopathy refers to a condition in which a person’s plasma cells produce an abnormal type of protein called monoclonal immunoglobulin or M protein. The presence of the M protein does not usually cause health problems, although in sufficient quantities it can lead to a type of blood cell cancer known as multiple myeloma. Because there are typically no physical symptoms related to monoclonal gammopathy, doctors usually recognize the condition only after examining blood samples for other problems. Treatment isn’t necessary, although people diagnosed with this condition are encouraged to schedule regular checkups with their doctors to make sure they don’t develop cancer.
Plasma cells are specialized white blood cells found in the bone marrow. They produce a number of important antibodies and other proteins that allow the immune system to function properly. Due to a random mutation in some plasma cells, they start producing quantities of M proteins. Because researchers aren’t sure what these proteins actually do, they often refer to the condition as monoclonal gammopathy of undetermined significance. Protein does not appear to hinder the functioning of the immune system unless extremely large amounts are present.
Large amounts of protein can prevent the production of other important white blood cells and proteins. The risk of developing blood cell and bone marrow cancers increases as the number of M proteins in the body increases. Some cases progress to multiple myeloma, a particularly devastating cancer that prevents the plasma from producing new antibodies. Multiple myeloma can lead to anemia, kidney failure, and serious bone problems.
Monoclonal gammopathy is most common in people over the age of 50, and the risk of developing the condition steadily increases as people continue to age. Research studies suggest that it is more likely to appear in men than in women. A doctor can diagnose monoclonal gammopathy by taking blood and urine samples for laboratory tests. Analysis of blood samples can reveal abnormalities in plasma cells and provide an accurate count of M proteins in the bloodstream. Additional tests, such as bone marrow biopsies and X-rays, can help doctors rule out multiple myeloma and other cancers when making a diagnosis.
Most patients with this condition, especially when the M protein count is very low, do not need medical attention. They are often required to schedule regular checkups with their doctors to monitor the progression of the disorder. Doctors test blood samples at regular intervals, usually about every six months, to check for multiple myeloma and other cancers. Noticing the warning signs of cancer early is essential to providing the most effective treatment.
Protect your devices with Threat Protection by NordVPN
